← Open Payments lookup

CONCEPCION MANGASEP: Open Payments

NPI 1861441701 · BUENA PARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,953 in 25 payments from 10 companies in 2025. Trend: 2023 $2,572 · 2024 $1,616 · 2025 $1,953

Food & beverage: $1,953
CompanyPaymentsAmount
Alkermes, Inc.8$546
Teva Pharmaceuticals USA, Inc.3$323
Otsuka America Pharmaceutical, Inc.2$244
Janssen Pharmaceuticals, Inc5$195
E.R. Squibb & Sons, L.L.C.2$152
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$127
Vanda Pharmaceuticals Inc.1$125
Axsome Therapeutics, Inc.1$124
Neurocrine BioSciences, Inc.1$96
ABBVIE INC.1$21

Products named: LYBALVI, UZEDY, INVEGA SUSTENNA, ARISTADA, COBENFY, CAPLYTA, FANAPT, REXULTI.

Industry payments across CA — which companies pay providers there.